IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
586.67
-3.33 (-0.56%)
At close: Aug 7, 2026, 4:00 PM EDT
584.00
-2.67 (-0.46%)
After-hours: Aug 7, 2026, 7:50 PM EDT
IDEXX Laboratories Employees
IDEXX Laboratories had 11,000 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$413,929
Profits / Employee
$103,605
Market Cap
46.22B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11,000 | 0 | - |
| Dec 31, 2024 | 11,000 | 0 | - |
| Dec 31, 2023 | 11,000 | 220 | 2.04% |
| Dec 31, 2022 | 10,780 | 430 | 4.15% |
| Dec 31, 2021 | 10,350 | 1,050 | 11.29% |
| Dec 31, 2020 | 9,300 | 100 | 1.09% |
| Dec 31, 2019 | 9,200 | 823 | 9.82% |
| Dec 31, 2018 | 8,377 | 777 | 10.22% |
| Dec 31, 2017 | 7,600 | 235 | 3.19% |
| Dec 31, 2016 | 7,365 | 565 | 8.31% |
| Dec 31, 2015 | 6,800 | 400 | 6.25% |
| Dec 31, 2014 | 6,400 | 700 | 12.28% |
| Dec 31, 2013 | 5,700 | 300 | 5.56% |
| Dec 31, 2012 | 5,400 | 300 | 5.88% |
| Dec 31, 2011 | 5,100 | 300 | 6.25% |
| Dec 31, 2010 | 4,800 | 0 | - |
| Dec 31, 2009 | 4,800 | 100 | 2.13% |
| Dec 31, 2008 | 4,700 | 0 | - |
| Dec 31, 2007 | 4,700 | 800 | 20.51% |
| Dec 31, 2006 | 3,900 | 600 | 18.18% |
| Dec 31, 2005 | 3,300 | 305 | 10.18% |
| Dec 31, 2004 | 2,995 | 522 | 21.11% |
| Dec 31, 2003 | 2,473 | 292 | 13.39% |
| Dec 31, 2002 | 2,181 | 11 | 0.51% |
| Dec 31, 2001 | 2,170 | -80 | -3.56% |
| Dec 31, 2000 | 2,250 | 200 | 9.76% |
| Dec 31, 1999 | 2,050 | -50 | -2.38% |
| Dec 31, 1998 | 2,100 | 0 | - |
| Dec 31, 1997 | 2,100 | 585 | 38.61% |
| Dec 31, 1996 | 1,515 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Danaher | 60,000 |
| Quest Diagnostics | 57,000 |
| Agilent Technologies | 18,100 |
| Mettler-Toledo International | 18,100 |
| Illumina | 10,080 |
| Waters | 7,900 |
IDXX News
- 3 days ago - Idexx Laboratories price target raised to $670 from $620 at UBS - TheFly
- 3 days ago - Idexx Laboratories price target raised to $670 from $650 at Citi - TheFly
- 4 days ago - Idexx Laboratories reports Q2 EPS $4.27, consensus $3.93 - TheFly
- 4 days ago - IDEXX Laboratories Earnings Call Transcript: Q2 2026 - Transcripts
- 4 days ago - IDEXX Laboratories Earnings release: Q2 2026 - Filings
- 4 days ago - IDEXX Laboratories Slides: Q2 2026 - Filings
- 4 days ago - IDEXX Laboratories Quarterly report: Q2 2026 - Filings
- 4 days ago - Idexx Laboratories raises FY26 EPS view to $14.69-$14.94 from $14.45-$14.90 - TheFly